Correspondence on “Decoding BRCA1 and BRCA2 mutations in high-grade serous ovarian cancer: impact of location and type of mutation on prognosis and PARP inhibitor treatment” by Momi et al

International Journal of Gynecological Cancer 2026

View at publisher

Authors: Ruoyi Xu, W.C.H. Cheng

DOI: 10.1016/j.ijgc.2026.104838

Cited by: 1

References: 3

Fields of Study & Subjects

PARP inhibition in cancer therapy BRCA gene mutations in cancer Ovarian cancer diagnosis and treatment

References 3